Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Biopharmaceuticals Contract Manufacturing Service Market by Type (Process Development, Manufacturing, Packaging), By Application (Peptides and Protein, Antibodies, Vaccines, Biosimilars, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Biopharmaceuticals Contract Manufacturing Service Market by Type (Process Development, Manufacturing, Packaging), By Application (Peptides and Protein, Antibodies, Vaccines, Biosimilars, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 231460 4200 Pharma & Healthcare 377 153 Pages 4.9 (47)
                                          

Industry Growth Insights published a new data on “Biopharmaceuticals Contract Manufacturing Service Market”. The research report is titled “Biopharmaceuticals Contract Manufacturing Service Market research by Types (Process Development, Manufacturing, Packaging), By Applications (Peptides and Protein, Antibodies, Vaccines, Biosimilars, Others), By Players/Companies Boehringer Ingelheim, Lonza Group, Rentschler Biotechnologie, JRS Pharma, Samsung BioLogics, WuXi Biologics, AGC Biologics, ProBioGen, FUJIFILM Diosynth Biotechnologies, Pfizer, Roche, Johnson & Johnson, Merck, Sanofi, AbbVie, GlaxoSmithKline, Takeda, Galentic Pharma, Novo Medi Sciences”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Biopharmaceuticals Contract Manufacturing Service Market Research Report

By Type

Process Development, Manufacturing, Packaging

By Application

Peptides and Protein, Antibodies, Vaccines, Biosimilars, Others

By Companies

Boehringer Ingelheim, Lonza Group, Rentschler Biotechnologie, JRS Pharma, Samsung BioLogics, WuXi Biologics, AGC Biologics, ProBioGen, FUJIFILM Diosynth Biotechnologies, Pfizer, Roche, Johnson & Johnson, Merck, Sanofi, AbbVie, GlaxoSmithKline, Takeda, Galentic Pharma, Novo Medi Sciences

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

153

Number of Tables & Figures

108

Customization Available

Yes, the report can be customized as per your need.


Global Biopharmaceuticals Contract Manufacturing Service Industry Outlook


Global Biopharmaceuticals Contract Manufacturing Service Market Report Segments:

The global Biopharmaceuticals Contract Manufacturing Service market is segmented on the basis of:

Types

Process Development, Manufacturing, Packaging

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Peptides and Protein, Antibodies, Vaccines, Biosimilars, Others

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Boehringer Ingelheim
  2. Lonza Group
  3. Rentschler Biotechnologie
  4. JRS Pharma
  5. Samsung BioLogics
  6. WuXi Biologics
  7. AGC Biologics
  8. ProBioGen
  9. FUJIFILM Diosynth Biotechnologies
  10. Pfizer
  11. Roche
  12. Johnson & Johnson
  13. Merck
  14. Sanofi
  15. AbbVie
  16. GlaxoSmithKline
  17. Takeda
  18. Galentic Pharma
  19. Novo Medi Sciences

Global Biopharmaceuticals Contract Manufacturing Service Market Overview


Highlights of The Biopharmaceuticals Contract Manufacturing Service Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Process Development
    2. Manufacturing
    3. Packaging
  1. By Application:

    1. Peptides and Protein
    2. Antibodies
    3. Vaccines
    4. Biosimilars
    5. Others
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Biopharmaceuticals Contract Manufacturing Service Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Biopharmaceuticals Contract Manufacturing Service Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Biopharmaceuticals Contract Manufacturing Service is a contract manufacturing service that helps pharmaceutical companies produce their products. This service can help companies save money by outsourcing the production of their products to a third-party manufacturer.

Some of the major players in the biopharmaceuticals contract manufacturing service market are Boehringer Ingelheim, Lonza Group, Rentschler Biotechnologie, JRS Pharma, Samsung BioLogics, WuXi Biologics, AGC Biologics, ProBioGen, FUJIFILM Diosynth Biotechnologies, Pfizer, Roche, Johnson & Johnson, Merck, Sanofi, AbbVie, GlaxoSmithKline, Takeda, Galentic Pharma, Novo Medi Sciences.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Biopharmaceuticals Contract Manufacturing Service Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Biopharmaceuticals Contract Manufacturing Service Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Biopharmaceuticals Contract Manufacturing Service Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Biopharmaceuticals Contract Manufacturing Service Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Biopharmaceuticals Contract Manufacturing Service Market Size & Forecast, 2018-2028       4.5.1 Biopharmaceuticals Contract Manufacturing Service Market Size and Y-o-Y Growth       4.5.2 Biopharmaceuticals Contract Manufacturing Service Market Absolute $ Opportunity

Chapter 5 Global Biopharmaceuticals Contract Manufacturing Service Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2 Biopharmaceuticals Contract Manufacturing Service Market Size Forecast by Type
      5.2.1 Process Development
      5.2.2 Manufacturing
      5.2.3 Packaging
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global Biopharmaceuticals Contract Manufacturing Service Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2 Biopharmaceuticals Contract Manufacturing Service Market Size Forecast by Applications
      6.2.1 Peptides and Protein
      6.2.2 Antibodies
      6.2.3 Vaccines
      6.2.4 Biosimilars
      6.2.5 Others
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Biopharmaceuticals Contract Manufacturing Service Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Biopharmaceuticals Contract Manufacturing Service Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America Biopharmaceuticals Contract Manufacturing Service Analysis and Forecast
   9.1 Introduction
   9.2 North America Biopharmaceuticals Contract Manufacturing Service Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America Biopharmaceuticals Contract Manufacturing Service Market Size Forecast by Type
      9.6.1 Process Development
      9.6.2 Manufacturing
      9.6.3 Packaging
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America Biopharmaceuticals Contract Manufacturing Service Market Size Forecast by Applications
      9.10.1 Peptides and Protein
      9.10.2 Antibodies
      9.10.3 Vaccines
      9.10.4 Biosimilars
      9.10.5 Others
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe Biopharmaceuticals Contract Manufacturing Service Analysis and Forecast
   10.1 Introduction
   10.2 Europe Biopharmaceuticals Contract Manufacturing Service Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe Biopharmaceuticals Contract Manufacturing Service Market Size Forecast by Type
      10.6.1 Process Development
      10.6.2 Manufacturing
      10.6.3 Packaging
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe Biopharmaceuticals Contract Manufacturing Service Market Size Forecast by Applications
      10.10.1 Peptides and Protein
      10.10.2 Antibodies
      10.10.3 Vaccines
      10.10.4 Biosimilars
      10.10.5 Others
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific Biopharmaceuticals Contract Manufacturing Service Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific Biopharmaceuticals Contract Manufacturing Service Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific Biopharmaceuticals Contract Manufacturing Service Market Size Forecast by Type
      11.6.1 Process Development
      11.6.2 Manufacturing
      11.6.3 Packaging
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific Biopharmaceuticals Contract Manufacturing Service Market Size Forecast by Applications
      11.10.1 Peptides and Protein
      11.10.2 Antibodies
      11.10.3 Vaccines
      11.10.4 Biosimilars
      11.10.5 Others
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America Biopharmaceuticals Contract Manufacturing Service Analysis and Forecast
   12.1 Introduction
   12.2 Latin America Biopharmaceuticals Contract Manufacturing Service Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America Biopharmaceuticals Contract Manufacturing Service Market Size Forecast by Type
      12.6.1 Process Development
      12.6.2 Manufacturing
      12.6.3 Packaging
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America Biopharmaceuticals Contract Manufacturing Service Market Size Forecast by Applications
      12.10.1 Peptides and Protein
      12.10.2 Antibodies
      12.10.3 Vaccines
      12.10.4 Biosimilars
      12.10.5 Others
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA) Biopharmaceuticals Contract Manufacturing Service Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA) Biopharmaceuticals Contract Manufacturing Service Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA) Biopharmaceuticals Contract Manufacturing Service Market Size Forecast by Type
      13.6.1 Process Development
      13.6.2 Manufacturing
      13.6.3 Packaging
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA) Biopharmaceuticals Contract Manufacturing Service Market Size Forecast by Applications
      13.10.1 Peptides and Protein
      13.10.2 Antibodies
      13.10.3 Vaccines
      13.10.4 Biosimilars
      13.10.5 Others
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Biopharmaceuticals Contract Manufacturing Service Market: Competitive Dashboard
   14.2 Global Biopharmaceuticals Contract Manufacturing Service Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Boehringer Ingelheim
      14.3.2 Lonza Group
      14.3.3 Rentschler Biotechnologie
      14.3.4 JRS Pharma
      14.3.5 Samsung BioLogics
      14.3.6 WuXi Biologics
      14.3.7 AGC Biologics
      14.3.8 ProBioGen
      14.3.9 FUJIFILM Diosynth Biotechnologies
      14.3.10 Pfizer
      14.3.11 Roche
      14.3.12 Johnson & Johnson
      14.3.13 Merck
      14.3.14 Sanofi
      14.3.15 AbbVie
      14.3.16 GlaxoSmithKline
      14.3.17 Takeda
      14.3.18 Galentic Pharma
      14.3.19 Novo Medi Sciences

Our Trusted Clients

Contact Us